A possibly important oncogene product in that context is RhoC GTPase (Van Golen et al, 2000a,2000b), which was found to be overexpressed in 90% of archival IBC tumour samples, but not in stage-matched non-IBC tumours. Here, RHOC is linked to inflammatory breast carcinoma.